Citations

Clear

4 citation(s) found for "Santos, Carlos".

Genomic Architecture of IRF4 Rearrangements in Children and Adult Large B-cell Lymphomas
Colmenero, Ariadna , Frauenfeld, Leonie , Mato, Sara , Salmerón‐Villalobos, Julia , Arredondo-Prats, Vicente , Ramis-Zaldivar, Joan E. , Montaner, Anna, Anta, Natalia Castrejón de , González‐Farré, Blanca , Garcia, Noelia, Andión, Maitane, Azorín, Daniel, Celis, Verónica , Rodríguez-Pinilla, Socorro Maria, Santos, Carlos Aliste, Hsi, Eric, Gheorghe, Gabriela, Schafernak, Kristian T. , Shestakova, A M, Gutierrez, Francisco Llamas, Hebeda, Konnie M. , Bhavsar, Tapan Mahendra, López-Guillermo, A, Ramis-Zaldivar, Joan Enric , Castrejon-de-Anta, Natalia , Verdú-Amorós, Jaime , Andrés, Mara , Andión, Maitane , Celis, Verónica , Santos, Carlos Aliste , Hsi, Eric D , Mariani, Rachel , Schafernak, Kristian , Menon, Madhu P , Hebeda, Konnie , López-Guillermo, Armando , Jaffe, Elaine S , Quintanilla-Martinez, Leticia , Campo, Elías , Nadeu, Ferran , Salaverria, Itziar , Verdú‐Amorós, Jaime , Rodríguez-Pinilla, Socorro Marıá , Hsi, Eric D. , Shestakova, Anna , Bhavsar, Tapan M., López‐Guillermo, Armando , Jaffe, Elaine S. , Quintanilla‐Martínez, Leticia , Campo, Elı́as , Nadeu, Ferran , Balagué, Olga , Salaverría, Itziar

Mayo Clinic

Blood Advances | July 17, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1182/bloodadvances.2026020477 | PMID 42466980 Get It

Large B-cell lymphoma with IRF4 rearrangement (LBCL-IRF4) predominantly affects children and young adults (CAYA) and presents as localized disease with excellent prognosis. Although most tumors harbor IRF4 rearrangements (IRF4-R), the existence of cryptic rearrangements has been suggested. Whether IRF4-R LBCL in adults represents the same biological entity remains unclear. To address this question, 35 CAYA patients diagnosed with LBCL-IRF4 and 7 adult (>40-year-old) LBCL with IRF4-R were investigated by an integrative molecular approach. Targeted sequencing structural variant analysis (SV-NGS) confirmed the IRF4-R in 84% of investigated cases. In CAYA, an enrichment (55% vs 29% in adults) of translocations involving IGH, with a breakpoint cluster 3' to IRF4 (EXOC2) was observed, including a cryptic insertion of IGHM-IGHJ5 into IRF4 locus. Novel translocations, IRF4::MIR142 in two CAYA (7%) and IRF4::BATF in one adult, were discovered. Whole-exome sequencing analysis identified unreported mutations in LBCL-IRF4 as YY1 and ZC3H12A (11% each). The high incidence of mutations affecting the B-cell receptor/NF-KB pathways in LBCL-IRF4 was confirmed in cases with diffuse component only. None of the CAYA tumors were classified by LymphGen tool. Adult IRF4-R LBCL showed higher levels of genetic complexity and a distinct mutational profile with mutations on KMT2D and DTX1 (43% each), and MYD88-L265P (29%), and were predicted as EZB or MCD (29% each). These differential genetic features were in line with different clinical presentations (extranodal involvement and advanced stage). In conclusion, IRF4-R architecture and mutational profile differ according to age, supporting that not all cases should be classified as LBCL-IRF4.
Intercellular adhesion molecule 1 links glioblastoma biology to a scalable prognostic model integrating clinical, imaging, and molecular features
Gandhi, Shreya, Ocaña-Tienda, Beatriz , Bettencourt, Manuel M., Singh, O, Devaraja, Kaviya , Irish, Emily R., Molina-García, David , Karimi, Shirin, Sosa, Julio , McIntyre, Ian, Gao, Andrew , Ramos-González, Ana, Asenjo, Beatriz , Flores-Rial, María Pino, Aldape, Kenneth , Santos, Carlos, Velásquez, Carlos, Mansouri, Alireza, Zadeh, Gelareh, Singh, Olivia S, Pérez-Beteta, Julián , Asenjo, Beatriz , Sánchez-Gómez, Pilar , Aldape, Kenneth D, Santos, Carlos , Mansouri, Alireza , Zadeh, Gelareh , Mansouri, Sheila , Mamatjan, Yasin , Hernández‐Laín, Aurelio , Drummond, Katharine Jann , Parney, Ian F. , Velásquez, Carlos , Mansouri, Alireza , Pérez‐García, Víctor M. , Mansouri, Sheila

Mayo Clinic

Neuro-Oncology Advances | July 10, 2026 | Volume: 8 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdag182 | PMID 42553785 Get It

Abstract Background Glioblastoma (GB) exhibits marked tumor microenvironmental heterogeneity, contributing to both therapy resistance and poor survival outcomes. Intercellular adhesion molecule 1 (ICAM1) is an inflammation-associated adhesion molecule implicated in immune-stromal interactions, but its clinical and biological significance in GB remains incompletely defined. Methods We performed ICAM1 immunohistochemistry, bulk RNA sequencing, DNA methylation analysis, single-nucleus RNA sequencing, and preoperative MRI-derived morphologic feature analysis across multi-institutional cohorts of treatment-naïve IDH-wildtype GB. Results High ICAM1 expression at both transcript and protein levels is associated with shorter overall survival, particularly within the mesenchymal transcriptional subtype. ICAM1 expression is inversely associated with promoter methylation. Single-nucleus RNA-sequencing analysis shows that ICAM1-high tumors are enriched for mesenchymal, hypoxia, stress-associated, and immunosuppressive myeloid programs, suggesting that ICAM1 reflects a multicompartment inflammatory tumor ecosystem. ICAM1 expression, tumor surface irregularity, and patient age are independently prognostic and minimally correlated, capturing complementary clinical, imaging, and molecular features of GB biology. When combined, our Clinical-Imaging-Molecular (CIM) framework refines outcome prediction across independent GB cohorts using routinely available clinical data, conventional imaging, and standard immunohistochemistry. Conclusions ICAM1 characterizes an immune-remodeled, stress-adapted GB ecosystem associated with poor clinical outcomes. Integrating patient age, surface irregularity, and ICAM1 expression yields a scalable and clinically accessible prognostic framework for GB, supporting tailored outcome prediction, particularly in low- and middle-resource settings without routine access to advanced molecular profiling.
Correlation of Symptoms, Clinical Signs, and Biomarkers of Inflammation in Postsurgical Chronic Rhinosinusitis
Racette, Samuel D. , Wijewickrama, Rohan C., Jayaprakash, Vijayvel , Sherris, David A., Kita, Hirohito , O’Donnell, Frank E., Ponikau, Jens U., Santos, Carlos Henrique Marques dos , Kita, H

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | April 5, 2017 | Volume: 126 | Issue: 6 | Pages: 455-462

10.1177/0003489417701939 | PMID 28376637 Get It

Objective: The study aimed to evaluate symptoms described by patients with chronic rhinosinusitis with polypoid changes/nasal polyps and their correlation with computed tomography (CT), nasal endoscopy, and intranasal biomarkers. Study Design: Prospective multicenter study symptom data from postsurgical adult chronic rhinosinusitis study participants with recurrent disease refractory to medical therapy were analyzed in comparison with objective data. Methods: Using logistic regression analysis, participant-rated 16-question surveys from 258 participants were assessed for correlation with nasal endoscopy scores, CT percentage of sinus occlusion, and intranasal biomarkers of fungal antigens (Alternaria and Aspergillus), eosinophilic inflammation (eosinophil-derived neurotoxin [EDN] and major basic protein [MBP]), and inflammatory cytokines (interleukins 5 and 13). Results: Study participant assessments revealed increased CT occlusion in participants presenting with greater inability to smell ( P < .019). Mucosal inflammation identified on nasal endoscopy was positively correlated with congestion ( P < .028), runny nose ( P < .002), and ear pain ( P < .007). Elevated EDN was positively correlated in patients with bothersome congestion ( P < .031) and runny nose ( P < .011). Sneezing was positively correlated with multiple markers: Alternaria ( P < .024), interleukin-13 ( P < .027), MBP ( P < .034), and interleukin-5 ( P < .019). Conclusion: Nasal endoscopy, not CT imaging, has the strongest correlation with the 2 cardinal symptoms of congestion and runny nose in CRS patients; these correlate with biomarkers of eosinophilic inflammation.
HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
Brum, Doralina Guimarães , Barreira, Amilton Antunes , Kaimen-Maciel, Damacio Ramón , Matiello, Marcelo , Deghaide, Neifi Hassan Saloun, Costa, Laudo Silva, Louzada‐Júnior, Paulo , Diniz, Paula Rejane Beserra , Mendes‐Junior, Celso Teixeira , Donadi, Eduardo Antônio , Santos, Antônio Carlos dos , Costa, Roberta Martins da Silva , Comini-Frota, Elizabeth Regina

Mayo Clinic

Multiple Sclerosis Journal | December 7, 2009 | Volume: 16 | Issue: 1 | Pages: 21-29

10.1177/1352458509350741 | PMID 19995845 Get It

Until recently, neuromyelitis optica (NMO) was considered to be a sub-type of multiple sclerosis (MS), which has a strong predilection for Caucasian populations, whereas NMO is more frequent in non-Caucasian individuals. The objective of this study was to compare the HLA-DRB profile in Brazilian Mulatto patients with NMO spectrum disorders (NMOSDs) with that observed for Mulatto MS patients and healthy Mulatto controls. Twenty seven NMOSD patients (20 women), all seropositive for NMO-IgG, 29 MS patients and 28 Mulatto healthy blood donors were evaluated for HLA-DRB allele groups. HLA-DRB1*03 allele group was overrepresented in NMO patients compared with healthy controls (p = 0.0401; OR = 3.23, 95%CI: 1.07—9.82). In contrast, the HLA-DRB1*15 allele group was overrepresented in Brazilian MS patients (OR = 15.89, 95%CI: 3.51—71.85; p < 0.0001). DRB3 was overrepresented in NMO (p = 0.0064), and DRB5 overrepresented in MS patients (p = 0.0001). The low frequency of HLA-DRB1*15 alleles was associated with the presence of long and central cord lesions at magnetic resonance. In addition, DRB1*15 alleles were associated with the fulfillment of the Barkhof criteria. In conclusion, these results indicate that the DRB profile of NMO patients is different from that observed for MS patients, further corroborating the distinction between NMO and MS.